The flaw in your logic is that it makes more sense to sit on GvHD until the Phase 2 results read-out. Why? Because between now and then, success is not a certainty. Retail investors, let alone big pharma, know and understand this.
The consequence of a deal now would be a significantly lower upfront payment, probably contingent on the results, anyway. It is likely that milestone and/or royalties would also be lower. So why not wait, and if the results are good, negotiate from a position of power?
Cynata's development has been a very slow burn, nearly 11 years since listing. I'm prepared to wait another 12-18 months if it means a GvHD deal will be more financially successful.
- Forums
- ASX - By Stock
- CYP
- Ann: Publication comparing Cymerus MSCs to other MSCs
CYP
cynata therapeutics limited
Add to My Watchlist
5.88%
!
16.0¢

Ann: Publication comparing Cymerus MSCs to other MSCs, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
-0.010(5.88%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 16.0¢ | $28.98K | 174.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 207290 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 11232 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 207290 | 0.155 |
7 | 323545 | 0.150 |
4 | 81775 | 0.145 |
5 | 315005 | 0.140 |
1 | 5000 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 11232 | 1 |
0.165 | 14675 | 1 |
0.170 | 40650 | 3 |
0.175 | 109733 | 4 |
0.180 | 175059 | 3 |
Last trade - 14.34pm 31/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |